RMI and FAF helpful in characterizing retinal dystrophies

Article

Using retro-mode imaging (RMI) and fundus autofluorescence (FAF) can be helpful in characterizing retinal dystrophies.

Using retro-mode imaging (RMI) and fundus autofluorescence (FAF) can be helpful in characterizing retinal dystrophies, according to a paper featured in the journal Bio Med. Central Ophthalmology.

A team led by Dr Battaglia Parodi Maurizio, Department of Ophthalmology, University Vita-Salute, Scientific Institute San Raffaele, Milan, Italy, included 18 consecutive patients with retinal dystrophies.

Each participant underwent ophthalmological assessments including best corrected visual acuity with ETDRS charts, blue-light fundus autofluorescence, (BL-FAF), near-infrared fundus autofluorescence (NIR-FAF) and RMI. The primary outcome was abnormal patterns on RMI and the secondary outcome was the correlation between BL-FAF findings and NIR-FAF findings.

The results revealed that the main feature of RMI is represented by a pseudo-3D pattern of all the posterior pole lesions. There were no fixed correlations between RMI, BL-AF and NIR-AF imaging. The non-invasive diagnostic tools could obtain additional information on clinical setting and patients monitoring.

Recent Videos
Durga Borkar, MD, MMCi, discusses FAS inhibition with ONL-1204
Theodore Leng, MD, MS, speaks about 12-Month Real-World Clinical and Anatomical Outcomes With Faricimab in Patients With Diabetic Macular Edema:The FARETINA-DME Study
Rishi P. Singh, MD, discussed his presentation on the results from part 1 of the Phase 2/3 SIGLEC trial assessing AVD-104 for GA
Carl C. Awh, MD, FASRS, speaks with Hattie Hayes of Ophthalmology Times Europe
Carl J. Danzig, MD
Martin Zinkernagel, MD, PhD, speaks about the ASRS sustainability expert panel
Srinivas Sai Kondapalli, MD, discusses outer retinal tubulations in lesion growth for subfoveal and non-subfoveal GA
Jennifer I. Lim, MD, FARVO, FASRS
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
© 2024 MJH Life Sciences

All rights reserved.